组织因子通路抑制剂通过调节CXCL12/CXCR4信号通路来促进MSCs的迁移,增殖和殖民
Miao Li1, Dongze Qiu2, Yufan Li1
1Department of Pulmonary Medicine, Zhongshan Hospital, Fudan University, Shanghai, 200032, China.
Biochemical and biophysical research communications
|July 13, 2025
概括
组织因子通路抑制剂 (TFPI) 增强介质干细胞 (MSC) 迁移和回归,改善肺损伤恢复. TFPI调节CXCL12/CXCR4通路,在肺损伤模型中促进MSC殖民和功能.
科学领域:
- 再生医学是一种再生医学.
- 细胞生物学 细胞生物学
- 肺部医学 肺部医学
背景情况:
- 介质细胞干细胞 (MSCs) 对肺损伤具有治疗潜力,但在受伤部位保持不良.
- 已知组织因子通路抑制剂 (TFPI) 可增强干细胞/原生细胞的迁移和回归.
- 将MSC与TFPI结合起来,可以克服MSC在肺损伤治疗中的保留限制.
研究的目的:
- 评估结合TFPI与MSC治疗肺损伤的疗效.
- 调查TFPI影响MSC行为和肺修复的潜在机制.
- 探索CXCL12/CXCR4信号通路在TFPI介导的MSC定位中的作用.
主要方法:
- 脂聚糖 (LPS) 诱导的急性肺损伤 (ALI) 鼠标模型用rhTFPI和/或MSCs治疗.
- 评估肺组织学,凝血功能,炎症标志物 (TNF-α,IL-1β) 和细胞殖民.
- 在体外测定MSC迁移,活力和繁殖;RNA测序用于基因表达分析.
- 对MSCs进行遗传操纵,以过度表达或击倒TFPI.
主要成果:
- 结合的rhTFPI和MSC治疗显著改善了肺损伤恢复和生存率.
- rhTFPI增强了MSC的生存能力,繁殖和迁移,促进了肺损伤部位的更好的殖民.
- RNA测序揭示了CXCL12作为一个关键的上调基因,表明它参与了治疗机制.
- TFPI水平调节了MSC的迁移,扩散和殖民,与CXCL12/CXCR4通路活性相关.
结论:
- 与MSC相结合的TFPI提供了一种有希望的策略,用于增强肺损伤的修复.
- 通过调节CXCL12/CXCR4信号通路,TFPI促进了MSC的迁移,扩散和定位,可能是通过调节CXCL12/CXCR4信号通路.
- 这项研究阐明了一种改善肺损伤干细胞治疗疗效的新机制.
相关概念视频
Mesenchymal Stem Cells
5.0K
Mesenchymal stem cells (MSCs) are adult stem cells that can differentiate into most connective tissue cell types, except for hematopoietic cells, depending upon the source of MSCs. For example, bone-marrow-derived MSCs (BM-MSCs) can differentiate into osteocytes, hepatocytes, and pancreatic and neuronal cells. MSCs can be isolated from various sources such as bone marrow, placenta, adipose tissue, teeth, and Wharton’s jelly, a gelatinous substance in the umbilical cord. The ease of their...
5.0K
Regulation of Hematopoietic Stem Cells
3.3K
All blood and immune cells are produced from the multipotent hematopoietic stem cells (HSCs) by the process of hematopoiesis. However, they all have a limited life span. In addition, many are depleted in immune surveillance or combatting an injury or infection. This makes blood one of the most regenerative tissues. Hematopoiesis helps replenish these blood and immune cells, restoring the body's normal functioning. However, overproduction of blood and immune cells can make them cancerous or...
3.3K
Regulation of Angiogenesis and Blood Supply
2.7K
Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits. Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl...
2.7K
TGF - β Signaling Pathway
7.7K
The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors...
7.7K
Intracellular Signaling Affects Focal Adhesions
2.8K
Integrins act both as extracellular input receivers and as intracellular processing activators. As their name suggests, integrins are entirely integrated into the membrane structure. Their hydrophobic membrane-spanning regions interact with the phospholipid bilayer's hydrophobic region. These membrane receptors provide extracellular attachment sites for effectors like hormones and growth factors. They activate intracellular response cascades when their effectors are bound and active.
Some...
Some...
2.8K


